Bicycle Therapeutics Plc (BCYC)
6.95
-0.36
(-4.92%)
USD |
NASDAQ |
Dec 17, 16:00
6.94
-0.01
(-0.14%)
After-Hours: 20:00
Bicycle Therapeutics Research and Development Expense (Annual): 216.26M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Adaptimmune Therapeutics Plc | 160.54M |
| Biodexa Pharmaceuticals Plc | 6.679M |
| NuCana Plc | 23.02M |
| Autolus Therapeutics Plc | 118.79M |
| Mereo BioPharma Group Plc | 20.94M |